Published in Vaccine on January 17, 2006
Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J Virol (2007) 1.54
Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity. J Virol (2011) 1.44
Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice. J Virol (2007) 1.16
The cross-reactivity of the enterovirus 71 to human brain tissue and identification of the cross-reactivity related fragments. Virol J (2010) 1.12
Production of EV71 vaccine candidates. Hum Vaccin Immunother (2012) 1.05
Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice. PLoS One (2012) 1.02
Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms. J Virol (2013) 0.94
Strategies to develop antivirals against enterovirus 71. Virol J (2013) 0.92
Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps. PLoS One (2013) 0.91
Highly attenuated Bordetella pertussis strain BPZE1 as a potential live vehicle for delivery of heterologous vaccine candidates. Infect Immun (2007) 0.88
Preclinical evaluation of the immunogenicity and safety of an inactivated enterovirus 71 candidate vaccine. PLoS Negl Trop Dis (2013) 0.80
Is a multivalent hand, foot, and mouth disease vaccine feasible? Hum Vaccin Immunother (2015) 0.79
Development of Novel Vaccines against Enterovirus-71. Viruses (2015) 0.78
Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease. PLoS Negl Trop Dis (2015) 0.78
Generation of the bovine viral diarrhea virus e0 protein in transgenic astragalus and its immunogenicity in sika deer. Evid Based Complement Alternat Med (2014) 0.77
Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in mice. Virol J (2014) 0.77
Therapeutic and prevention strategies against human enterovirus 71 infection. World J Virol (2015) 0.77
Enterovirus 71 infection and vaccines. Clin Exp Vaccine Res (2017) 0.75
Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge. Virol J (2014) 0.75
Characterization of the enterovirus 71 P1 polyprotein expressed in Pichia pastor as a candidate vaccine. Hum Vaccin Immunother (2014) 0.75
Systemic antibody response to nano-size calcium phospate biocompatible adjuvant adsorbed HEV-71 killed vaccine. Clin Exp Vaccine Res (2015) 0.75
A transgenic ginseng vaccine for bovine viral diarrhea. Virol J (2015) 0.75
Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology (2004) 2.74
Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics (2009) 1.85
Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71. Pediatr Res (2006) 1.50
Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis (2008) 1.43
Quantitative assessment of allergic shiners in children with allergic rhinitis. J Allergy Clin Immunol (2009) 1.41
Antitumor and antimetastatic activity of IL-23. J Immunol (2003) 1.38
Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology (2006) 1.21
Polysaccharide purified from Ganoderma lucidum induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and p38 mitogen-activated protein kinase pathways. J Leukoc Biol (2005) 1.20
Clinical characteristics of childhood erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in Taiwanese children. J Microbiol Immunol Infect (2004) 1.20
Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis. J Autoimmun (2006) 1.17
Epidemiologic features of Kawasaki disease in Taiwan, 1996-2002. Pediatrics (2004) 1.15
The immunobiology of Henoch-Schönlein purpura. Autoimmun Rev (2007) 1.13
Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecoline. Carcinogenesis (2003) 1.12
Proteomics and immunological analysis of a novel shrimp allergen, Pen m 2. J Immunol (2003) 1.12
Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus. Immunology (2008) 1.09
Clinical manifestations and outcomes of Henoch-Schönlein purpura: comparison between adults and children. Pediatr Neonatol (2009) 1.07
Enterovirus 71 virus-like particle vaccine: improved production conditions for enhanced yield. Vaccine (2010) 1.07
Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles. Vaccine (2011) 1.02
Proteome mining for novel IgE-binding proteins from the German cockroach (Blattella germanica) and allergen profiling of patients. Proteomics (2010) 1.01
Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases. Clin Rheumatol (2012) 1.00
Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives. J Autoimmun (2005) 1.00
Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics. Ann Allergy Asthma Immunol (2007) 0.99
Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock. Life Sci (2003) 0.99
Necrotizing pneumococcal pneumonia in children: the role of pulmonary gangrene. Pediatr Pulmonol (2006) 0.99
Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome. J Formos Med Assoc (2005) 0.97
The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis. Autoimmun Rev (2011) 0.96
The protease allergen Pen c 13 induces allergic airway inflammation and changes in epithelial barrier integrity and function in a murine model. J Biol Chem (2011) 0.95
Impact of maternal and neonatal factors on CD34+ cell count, total nucleated cells, and volume of cord blood. Pediatr Transplant (2008) 0.95
Regulatory T cells negatively regulate neovasculature of airway remodeling via DLL4-Notch signaling. J Immunol (2009) 0.94
An immunomodulatory protein, Ling Zhi-8, induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and MAPK pathways. J Leukoc Biol (2009) 0.94
Patient data, early SARS epidemic, Taiwan. Emerg Infect Dis (2004) 0.94
A new insight into hepatitis C vaccine development. J Biomed Biotechnol (2010) 0.94
Renal manifestations in Henoch-Schönlein purpura: a 10-year clinical study. Pediatr Nephrol (2005) 0.93
Juvenile idiopathic arthritis-associated uveitis: a nationwide population-based study in Taiwan. PLoS One (2013) 0.93
Shikonin inhibits maturation of bone marrow-derived dendritic cells and suppresses allergic airway inflammation in a murine model of asthma. Br J Pharmacol (2010) 0.92
A novel phycobiliprotein alleviates allergic airway inflammation by modulating immune responses. Am J Respir Crit Care Med (2010) 0.92
Sex differences in spontaneous versus induced animal models of autoimmunity. Autoimmun Rev (2011) 0.92
Lentiviral-mediated GATA-3 RNAi decreases allergic airway inflammation and hyperresponsiveness. Mol Ther (2007) 0.91
Over-expression of receptor activator of nuclear factor-kappaB ligand (RANKL), inflammatory cytokines, and chemokines in periprosthetic osteolysis of loosened total hip arthroplasty. Biomaterials (2009) 0.91
Propolis extracts exhibit an immunoregulatory activity in an OVA-sensitized airway inflammatory animal model. Int Immunopharmacol (2006) 0.91
Prostaglandin E2 potentiates mesenchymal stem cell-induced IL-10+IFN-γ+CD4+ regulatory T cells to control transplant arteriosclerosis. J Immunol (2013) 0.91
Methimazole-induced lupus erythematosus: a case report. J Microbiol Immunol Infect (2003) 0.91
Nitric oxide activates superoxide dismutase and ascorbate peroxidase to repress the cell death induced by wounding. Plant Mol Biol (2011) 0.91
Lack of association between infection with a novel human coronavirus (HCoV), HCoV-NH, and Kawasaki disease in Taiwan. J Infect Dis (2005) 0.90
Retrospective analysis of mortality and morbidity of pediatric systemic lupus erythematosus in the past two decades. J Microbiol Immunol Infect (2003) 0.90
Increased levels of serum-specific immunoglobulin e to staphylococcal enterotoxin a and B in patients with allergic rhinitis and bronchial asthma. Int Arch Allergy Immunol (2005) 0.90
Genetics and immunopathogenesis of IgA nephropathy. Clin Rev Allergy Immunol (2011) 0.89
Correlation between age and allergens in pediatric atopic dermatitis. Ann Allergy Asthma Immunol (2004) 0.89
Regulatory T cells induced by mucosal B cells alleviate allergic airway hypersensitivity. Am J Respir Cell Mol Biol (2011) 0.89
Involvement of hydrogen peroxide and nitric oxide in expression of the ipomoelin gene from sweet potato. Plant Physiol (2003) 0.89
Aortic aneurysm in systemic lupus erythematosus. J Microbiol Immunol Infect (2004) 0.88
Separation and detection of rare cells in a microfluidic disk via negative selection. Lab Chip (2010) 0.88
Linoleic acid metabolite levels and transepidermal water loss in children with atopic dermatitis. Ann Allergy Asthma Immunol (2008) 0.88
Co-delivery of GM-CSF gene enhances the immune responses of hepatitis C viral core protein-expressing DNA vaccine: role of dendritic cells. J Med Virol (2002) 0.88
Role of bacterial pathogens in atopic dermatitis. Clin Rev Allergy Immunol (2007) 0.88
Dermatophagoides pteronyssinus 2 regulates nerve growth factor release to induce airway inflammation via a reactive oxygen species-dependent pathway. Am J Physiol Lung Cell Mol Physiol (2010) 0.87
α-Galactosylceramide-induced airway eosinophilia is mediated through the activation of NKT cells. J Immunol (2011) 0.87
Type I IL-1 receptor (IL-1RI) as potential new therapeutic target for bronchial asthma. Mediators Inflamm (2010) 0.87
Effects of overexpression of IL-10, IL-12, TGF-beta and IL-4 on allergen induced change in bronchial responsiveness. Respir Res (2006) 0.86
Placental growth factor down-regulates type 1 T helper immune response by modulating the function of dendritic cells. J Leukoc Biol (2007) 0.86
Cyclosporin A therapy for steroid-dependent Henoch-Schönlein purpura. J Microbiol Immunol Infect (2003) 0.86
Ganoderma tsugae supplementation alleviates bronchoalveolar inflammation in an airway sensitization and challenge mouse model. Int Immunopharmacol (2005) 0.86
Fas-ligand-expressing adenovirus-transfected dendritic cells decrease allergen-specific T cells and airway inflammation in a murine model of asthma. J Mol Med (Berl) (2006) 0.86
The effect of caffeic acid phenethyl ester on the functions of human monocyte-derived dendritic cells. BMC Immunol (2009) 0.86
Effects of adenovirus-expressing IL-10 in alleviating airway inflammation in asthma. J Gene Med (2006) 0.85
Autologous mesenchymal stem cells prevent transplant arteriosclerosis by enhancing local expression of interleukin-10, interferon-γ, and indoleamine 2,3-dioxygenase. Cell Transplant (2012) 0.85
Thrombopoietin and interleukin-6 levels in Henoch-Schönlein purpura. J Microbiol Immunol Infect (2006) 0.85
Kikuchi-Fujimoto disease in children: clinical features and disease course. J Microbiol Immunol Infect (2004) 0.84
Selective silencing of DNA-specific B lymphocytes delays lupus activity in MRL/lpr mice. Eur J Immunol (2007) 0.84
Ribavirin for respiratory syncytial virus bronchiolitis reduced the risk of asthma and allergen sensitization. Pediatr Allergy Immunol (2008) 0.84
Different familial association patterns of autoimmune diseases between juvenile-onset systemic lupus erythematosus and juvenile rheumatoid arthritis. J Microbiol Immunol Infect (2004) 0.84
Identification of cucurbitacins and assembly of a draft genome for Aquilaria agallocha. BMC Genomics (2014) 0.83
Distribution, clinical features and treatment in Taiwanese patients with symptomatic primary immunodeficiency diseases (PIDs) in a nationwide population-based study during 1985-2010. Immunobiology (2011) 0.83
Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model. Int J Cancer (2009) 0.83
Cardiopulmonary involvement in pediatric systemic lupus erythematosus: a twenty-year retrospective analysis. J Microbiol Immunol Infect (2007) 0.83
Increased serum interleukin-17 and peripheral Th17 cells in children with acute Henoch-Schönlein purpura. Pediatr Allergy Immunol (2011) 0.83
Interleukin-21 suppresses the differentiation and functions of T helper 2 cells. Immunology (2015) 0.83
Antinucleosome antibodies correlate with the disease severity in children with systemic lupus erythematosus. J Autoimmun (2006) 0.83
Identification of anti-prothrombin antibodies in the anti-phospholipid syndrome that display the prothrombinase activity. Rheumatology (Oxford) (2009) 0.82
Functional impairment of dendritic cells in patients infected with hepatitis C virus genotype 1 who failed peginterferon plus ribavirin therapy. J Med Virol (2011) 0.82
Administration of polysaccharides from Antrodia camphorata modulates dendritic cell function and alleviates allergen-induced T helper type 2 responses in a mouse model of asthma. Immunology (2009) 0.82
Analysis of serum total IgE, specific IgE and eosinophils in children with acute and chronic urticaria. J Microbiol Immunol Infect (2012) 0.82
Hepatitis B virus surface antigen can activate human monocyte-derived dendritic cells by nuclear factor kappa B and p38 mitogen-activated protein kinase mediated signaling. Microbiol Immunol (2012) 0.82
Expression of an Oncidium gene encoding a patatin-like protein delays flowering in Arabidopsis by reducing gibberellin synthesis. Plant Cell Physiol (2011) 0.82
Frequency and phenotypic analysis of CD4+CD25+ regulatory T cells in children with juvenile idiopathic arthritis. J Microbiol Immunol Infect (2008) 0.82
Response to influenza vaccine in children with leukemia undergoing chemotherapy. J Formos Med Assoc (2002) 0.82
Food-specific immunoglobulin E among children with atopic dermatitis: a retrospective study. J Microbiol Immunol Infect (2005) 0.82
siRNA as a therapy for asthma. Curr Opin Mol Ther (2009) 0.82
Interaction of small RNA-8105 and the intron of IbMYB1 RNA regulates IbMYB1 family genes through secondary siRNAs and DNA methylation after wounding. Plant J (2013) 0.82
The genetics of atopic dermatitis. Clin Rev Allergy Immunol (2007) 0.82
Natural killer cell deficiency associated with Hodgkin's lymphoma: a case report. J Formos Med Assoc (2002) 0.82
Analysis of the serum levels of fungi-specific immunoglobulin E in patients with allergic diseases. Int Arch Allergy Immunol (2010) 0.82
The initial manifestations and final diagnosis of patients with high and low titers of antinuclear antibodies after 6 months of follow-up. J Microbiol Immunol Infect (2011) 0.82
Strategies of mucosal immunotherapy for allergic diseases. Cell Mol Immunol (2011) 0.81
Clinical applicability of the World Health Organization Quality of Life Scale Brief Version (WHOQOL-BREF) to mothers of children with asthma in Taiwan. J Clin Nurs (2010) 0.81
A nationwide survey of the severity, comorbidity, and mortality of hospitalized patients with asthma in Taiwan. Pediatr Neonatol (2013) 0.81
Induction of shrimp tropomyosin-specific hypersensitivity in mice. Int Arch Allergy Immunol (2008) 0.81
Noninvasive in vitro and in vivo assessment of epidermal hyperkeratosis and dermal fibrosis in atopic dermatitis. J Biomed Opt (2009) 0.81
Antiallergic asthma properties of brazilin through inhibition of TH2 responses in T cells and in a murine model of asthma. J Agric Food Chem (2012) 0.81